Table 3.
Univariate and multivariate analysis of overall survival in 49 patients with hilar cholangiocarcinoma according to clinicopathological factors and AKR1C1 overexpression.
| Clinicopathological factor | Case (n) | OS(mo) | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|---|---|
| χ2 | P | χ2 | P | HR(95%CI) | |||
| T stage | |||||||
| T1-3 | 7 | 50 | 7.559 | 0.006 | 6.172 | 0.013 | 0.153(0.035-0.672) |
| T4 | 42 | 16 | |||||
| N stage | |||||||
| No | 16 | 42 | 5.602 | 0.018 | 3.343 | 0.067 | 0.459(0.199-1.058) |
| Yes | 33 | 14 | |||||
| Differentiation | |||||||
| High/moderate | 37 | 23 | 3.640 | 0.056 | NA | ||
| poor/un-differentiated | 12 | 16 | |||||
| Positive margin | |||||||
| No | 23 | 26 | 4.096 | 0.043 | NA | ||
| Yes | 26 | 16 | |||||
| AKR1C1 | |||||||
| Negative | 19 | 50 | 24.923 | <0.001 | NA | ||
| Positive | 30 | 13 | |||||